Trials / Completed
CompletedNCT01669291
Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation
Effect of GnRH Antagonist Protocol vs Agonist Long Protocol During Controlled Hyperstimulation (COH)for Assisted Reproduction on IVF Outcome, Peak Estradiol Level, and Duration of Stimulation.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- Main Line Fertility Center · Academic / Other
- Sex
- Female
- Age
- 21 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine if utilizing GnRH antagonists versus agonist long protocol during controlled ovarian stimulation (COH) with human-derived gonadotropins for assisted reproduction affects IVF outcome, peak estradiol level, and duration of stimulation.
Detailed description
No detailed description
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bravelle and Menopur | Bravelle and Menopur are used for controlled ovarian stimulation (COH) |
| DRUG | Agonist | Agonist (Lupron) is used to suppress endogenous pituitary LH for the premature LH surges. |
| DRUG | Antagonist | Ganirelix acetate or cetrorelix acetate Agonist is used to suppress endogenous pituitary LH for the premature LH surges. |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2012-08-21
- Last updated
- 2014-06-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01669291. Inclusion in this directory is not an endorsement.